Masana'antar Na'urar Likita Outlook Y2021-Y2025

Masana'antar na'urorin likitancin kasar Sin a ko da yaushe ta kasance wani bangare mai saurin tafiya, kuma yanzu an sanya shi a matsayin kasuwa na biyu mafi girma a fannin kiwon lafiya a duniya.Dalilin haɓaka cikin sauri shine saboda karuwar kashe kuɗin kiwon lafiya a cikin kayan aikin likita, magunguna, asibiti da inshorar kula da lafiya.Bayan haka, ƴan wasan gida da yawa suna tsalle cikin kasuwa kuma manyan ƴan wasan suna saurin canza fasahar data kasance tare da haɓaka sabbin kayayyaki.

Sakamakon Covid-19, kasar Sin tana cikin saurin bunkasuwar kayayyakin na'urorin likitanci da nufin cim ma sahibin sahihancinsu.A sa'i daya kuma, ana ci gaba da bullo da sabbin kayayyaki da sabbin fasahohin magani a kasuwanni wadanda ke kawo saurin bunkasuwar masana'antar na'urorin likitanci, musamman saurin bunkasuwar manyan kamfanoni a kowane fanni.

A cikin 'yan shekarun nan, kasar Sin ta shiga wani zamani na bunkasa kayayyaki da fasahohi, irinsu stent da Lepu Medical ta harba, bututun IVD da Antu Biotech da Mindray Medical suka harba, da na'urar binciken kwayoyin halitta ta Nanwei Medical ta samar da kuma sayar da ita.The high-karshen launi duban dan tayi kayayyakin samar da Mindray Medical da Kaili Medical, da kuma manyan sikelin hoto kayan aiki na United Imaging Medical suna da ikon daidaita shigo da tsakiyar- da high-karshen kayayyakin a cikin filayen, ta haka forming wani matsakaici karfi a cikin. kirkire-kirkire da inganta kayan aikin likitancin kasar Sin..

A cikin 2019, na'urorin likitancin kasar Sin da aka jera kamfanoni suna da babban gibin kudaden shiga.Kamfanoni 20 na farko da ke da mafi girman kudaden shiga su ne Mindray Medical, inda kudaden shiga ya kai biliyan 16.556, kuma kamfani mafi karanci shi ne Zhende Medical, yana da kudin shiga kusan yuan biliyan 1.865.Yawan karuwar kudaden shiga na Top20 da aka jera kudaden shiga na kamfanoni na shekara-shekara yana kan matsayi mai girma.Manyan kamfanoni 20 da aka lissafa a cikin kudaden shiga ana rarraba su ne a Shandong, Guangdong da Zhejiang.

Yawan tsufa na kasar Sin yana karuwa da sauri fiye da sauran kasashe na duniya.Tare da saurin tsufa na yawan jama'a, karuwar yawan shigar azzakari cikin farji a cikin abubuwan da ake iya zubarwa sun haɓaka haɓakar saurin haɓaka kasuwar na'urar likitanci.

Ciwon daji da cututtukan zuciya na ci gaba da haɓakawa kuma aikace-aikacen da aka haɓaka ingantaccen sikanin a cikin asibitin yana ci gaba da girma, wanda ke ƙaruwa da amfani da kayan aikin rediyo mai ƙarfi.An kiyasta adadin girman girman binciken ya kai miliyan 194 a cikin 2022 idan aka kwatanta da miliyan 63 a cikin 2015.

Madaidaicin ganewar asali yana buƙatar mafi girman tsabtar hoto da daidaiton fasahar hoto.

Wata manufa ta masana'antar na'urorin likitanci tana daidai da Mataki na 35 na "Dokokin Kulawa da Gudanar da Na'urorin Likita".Ya kayyade cewa ba za a yi amfani da na'urorin likitanci guda ɗaya ba akai-akai.Ya kamata a lalata kayan da aka yi amfani da su na likitanci kuma a rubuta su daidai da ƙa'idodi. Haramcin abubuwan da za a iya zubarwa da kyau ya hana wasu asibitoci sake yin amfani da kayan aikin rediyo mai ƙarfi don adana farashi.

Dangane da abubuwan da ke sama, masana'antar na'urorin likitanci suna ƙarƙashin babban canji.Adadin haɓakar fili na shekara-shekara kusan 28% ne.Antmed shine jagorasirinji mai matsa lambayi a China kuma muna zuba jari sosai a cikin tsarin R&D.Muna fatan ba da gudummawa ga masana'antar likitancin kasar Sin da kuma kula da matsayin jagoran masana'antarmu.

26d166e5


Lokacin aikawa: Fabrairu-26-2021

Bar Saƙonku: